ArticleJournal of managed care & specialty pharmacy2018

Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer.

Lixian Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.